Insys Therapeutics Inc (INSYQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2019 | 12-2018 | 09-2018 | 06-2018 | 03-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 36,513 | 31,552 | 20,845 | 16,090 | 18,549 |
| Marketable Securities | 47,380 | 64,126 | 79,719 | 88,813 | 95,895 |
| Receivables | 6,087 | 12,610 | 12,717 | 20,067 | 15,761 |
| Inventories | 7,246 | 8,608 | 10,754 | 10,001 | 16,300 |
| TOTAL | $105,727 | $126,292 | $145,477 | $156,114 | $166,694 |
| Non-Current Assets | |||||
| PPE Net | 47,810 | 52,086 | 53,180 | 52,892 | 54,777 |
| Investments And Advances | 3,726 | 8,446 | 12,451 | 18,605 | 31,633 |
| Other Non-Current Assets | 15,337 | 5,703 | 6,383 | 7,534 | 835 |
| TOTAL | $66,873 | $66,235 | $72,014 | $79,031 | $87,245 |
| Total Assets | $172,600 | $192,527 | $217,491 | $235,145 | $253,939 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 67,095 | 50,778 | 46,047 | 33,569 | 29,440 |
| Accrued Expenses | 125,062 | 56,001 | 165,307 | 168,038 | 168,371 |
| TOTAL | $195,215 | $106,779 | $211,354 | $201,607 | $197,811 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 141,109 | 128,848 | 5,999 | 8,901 | 8,765 |
| TOTAL | $141,109 | $128,848 | $5,999 | $8,901 | $8,765 |
| Total Liabilities | $336,324 | $235,627 | $217,353 | $210,508 | $206,576 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 74,569 | 74,428 | 74,270 | 74,245 | 73,809 |
| Common Shares | 745 | 744 | 743 | 742 | 738 |
| Retained earnings | -459,927 | -336,083 | -289,790 | -262,223 | -234,873 |
| Other shareholders' equity | -176 | -269 | -349 | -438 | -550 |
| TOTAL | $-163,724 | $-43,100 | $138 | $24,637 | $47,363 |
| Total Liabilities And Equity | $172,600 | $192,527 | $217,491 | $235,145 | $253,939 |